Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 9Thoracic 4Breast 3Gastrointestinal 2Dermatologic 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Lymphoma 8Lymphoma, Large B-Cell, Diffuse 6Hodgkin Disease 6Lymphoma, Follicular 3Breast Neoplasms 3Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Triple Negative Breast Neoplasms 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroendocrine Tumors 1Mycosis Fungoides 1Mesothelioma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Glioblastoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

fludarabine phosphate 7pembrolizumab 6Mycophenolic Acid 6Peripheral Blood Stem Cell Transplantation 5Nivolumab 5Cyclosporine 5Cyclophosphamide 5Whole-Body Irradiation 4Radiotherapy 3Busulfan 3Antilymphocyte Serum 3temsirolimus 2fludarabine 2atezolizumab 2alectinib 2Tacrolimus 2Sunitinib 2Specimen Handling 2Paclitaxel 2Methotrexate 2Magnetic Resonance Spectroscopy 2Drug Therapy 2Dasatinib 2Alemtuzumab 2varlilumab 1valspodar 1utomilumab 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Fluorodeoxyglucose F18 × Lymphoid × Clear all
NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Stanford University

Phase 2 Completed
7 enrolled 6 charts
BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡